About Scienture Holdings, Inc. - Common Stock (SCNX)
Scienture Holdings, Inc. is a biotechnology company focused on developing innovative solutions for the healthcare industry. The company specializes in the advancement of novel therapeutics and diagnostic technologies, aiming to address significant medical needs and improve patient outcomes. Through a combination of research, development, and strategic partnerships, Scienture is committed to bringing cutting-edge products to market that enhance the quality of care in various therapeutic areas. Read More
Let's delve into the US markets on Friday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Major U.S. indices closed higher on Thursday, with the Dow Jones Industrial Average up 0.3% at 46,734.61, the S&P 500 advancing nearly 0.6% to 6,738.44.
Intrigued by the market activity one hour before the close of the markets on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.
Specificity, Inc. (OTCQB: SPTY), a fast-scaling ad tech disruptor redefining digital marketing precision, has seen its stock skyrocket 933% this week, rallying from an intraday low of $0.15 on October 16 to an intraday high of $1.40 on October 22 , as Wall Street responds enthusiastically to the company’s new executive appointments and aggressive growth trajectory.
Scienture Holdings, Inc. announced GPO agreements for its new drug, Arbli, providing access to over 2,500 healthcare institutions and plans to expand further.
